Literature DB >> 15221356

PASSCLAIM--gut health and immunity.

John H Cummings1, Jean-Michel Antoine, Fernando Azpiroz, Raphaelle Bourdet-Sicard, Per Brandtzaeg, Philip C Calder, Glenn R Gibson, Francisco Guarner, Erika Isolauri, Daphne Pannemans, Colette Shortt, Sandra Tuijtelaars, Bernhard Watzl.   

Abstract

BACKGROUND: The gut and immune system form a complex integrated structure that has evolved to provide effective digestion and defence against ingested toxins and pathogenic bacteria. However, great variation exists in what is considered normal healthy gut and immune function. Thus, whilst it is possible to measure many aspects of digestion and immunity, it is more difficult to interpret the benefits to individuals of variation within what is considered to be a normal range. Nevertheless, it is important to set standards for optimal function for use both by the consumer, industry and those concerned with the public health. The digestive tract is most frequently the object of functional and health claims and a large market already exists for gut-functional foods worldwide. AIM: To define normal function of the gut and immune system and describe available methods of measuring it.
RESULTS: We have defined normal bowel habit and transit time, identified their role as risk factors for disease and how they may be measured. Similarly, we have tried to define what is a healthy gut flora in terms of the dominant genera and their metabolism and listed the many, varied and novel methods for determining these parameters. It has proved less easy to provide boundaries for what constitutes optimal or improved gastric emptying, gut motility, nutrient and water absorption and the function of organs such as the liver, gallbladder and pancreas. The many tests of these functions are described. We have discussed gastrointestinal well being. Sensations arising from the gut can be both pleasant and unpleasant. However, the characteristics of well being are ill defined and merge imperceptibly from acceptable to unacceptable, a state that is subjective. Nevertheless, we feel this is an important area for future work and method development. The immune system is even more difficult to make quantitative judgements about. When it is defective, then clinical problems ensure, but this is an uncommon state. The innate and adaptive immune systems work synergistically together and comprise many cellular and humoral factors. The adaptive system is extremely sophisticated and between the two arms of immunity there is great redundancy, which provides robust defences. New aspects of immune function are discovered regularly. It is not clear whether immune function can be "improved". Measuring aspects of immune function is possible but there is no one test that will define either the status or functional capacity of the immune system. Human studies are often limited by the ability to sample only blood or secretions such as saliva but it should be remembered that only 2% of lymphocytes circulate at any given time, which limits interpretation of data. We recommend assessing the functional capacity of the immune system by: measuring specific cell functions ex vivo. measuring in vivo responses to challenge, e. g. change in antibody in blood or response to antigens. determining the incidence and severity of infection in target populations during naturally occurring episodes or in response to attenuated pathogens.

Entities:  

Mesh:

Year:  2004        PMID: 15221356     DOI: 10.1007/s00394-004-1205-4

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   5.614


  59 in total

1.  High-level dietary fibre up-regulates colonic fermentation and relative abundance of saccharolytic bacteria within the human faecal microbiota in vitro.

Authors:  Qing Shen; Lu Zhao; Kieran M Tuohy
Journal:  Eur J Nutr       Date:  2011-09-28       Impact factor: 5.614

2.  The prevalence of bacterial contamination of surgical cold sterile solutions from community companion animal veterinary practices in southern Ontario.

Authors:  Colleen P Murphy; J Scott Weese; Richard J Reid-Smith; Scott A McEwen
Journal:  Can Vet J       Date:  2010-06       Impact factor: 1.008

Review 3.  Host-microbiome interaction in Crohn's disease: A familiar or familial issue?

Authors:  Andrea Michielan; Renata D'Incà
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15

Review 4.  PASSCLAIM: consensus on criteria.

Authors:  Peter J Aggett; Jean-Michel Antoine; Nils-Georg Asp; France Bellisle; Laura Contor; John H Cummings; John Howlett; Detlef J G Müller; Christoph Persin; Loek T J Pijls; Gerhard Rechkemmer; Sandra Tuijtelaars; Hans Verhagen
Journal:  Eur J Nutr       Date:  2005-06       Impact factor: 5.614

5.  Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients.

Authors:  Haifeng Lu; Zhongwen Wu; Wei Xu; Jiezuan Yang; Yunbo Chen; Lanjuan Li
Journal:  Microb Ecol       Date:  2011-02-01       Impact factor: 4.552

Review 6.  Probiotics and gut health: a special focus on liver diseases.

Authors:  Silvia Wilson Gratz; Hannu Mykkanen; Hani S El-Nezami
Journal:  World J Gastroenterol       Date:  2010-01-28       Impact factor: 5.742

7.  The process for the assessment of scientific support for claims on food.

Authors:  Peter J Aggett
Journal:  Eur J Nutr       Date:  2009-12       Impact factor: 5.614

Review 8.  Inflammation in irritable bowel syndrome: Myth or new treatment target?

Authors:  Emanuele Sinagra; Giancarlo Pompei; Giovanni Tomasello; Francesco Cappello; Gaetano Cristian Morreale; Georgios Amvrosiadis; Francesca Rossi; Attilio Ignazio Lo Monte; Aroldo Gabriele Rizzo; Dario Raimondo
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

9.  Characterization of intestinal inflammation and identification of related gene expression changes in mdr1a(-/-) mice.

Authors:  Y E M Dommels; C A Butts; S Zhu; M Davy; S Martell; D Hedderley; M P G Barnett; W C McNabb; N C Roy
Journal:  Genes Nutr       Date:  2007-09-27       Impact factor: 5.523

10.  Ability of probiotic Lactobacillus casei DN 114001 to bind or/and metabolise heterocyclic aromatic amines in vitro.

Authors:  Adriana Nowak; Zdzislawa Libudzisz
Journal:  Eur J Nutr       Date:  2009-05-16       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.